| Ekso Bionics Holdings designs, develops, and sells exoskeleton technology that has applications in healthcare and industrial markets. Co.'s exoskeleton technology serves several markets and can be used both by able-bodied users as well as by persons with physical disabilities. Co. has sold, rented or leased devices that enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again; and allow industrial workers to perform heavy duty work for extended periods. Co.'s product, the Ekso GT, is a wearable bionic suit that is used by its hospital and rehabilitation customers in both in-patient and out-patient settings. We show 21 historical shares outstanding datapoints in our EKSO shares outstanding history coverage, used to compute EKSO market cap on those dates.|
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing EKSO market cap history over the course of time is important for investors
interested in comparing EKSO's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of EKSO versus a peer is one thing; comparing
EKSO market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like EKSO can fluctuate over the course of history.
With this page we aim to empower investors researching EKSO by allowing them to research the EKSO market cap history.